Home9620 • TADAWUL
add
Balsm Alofoq Medical Company CJSC
Previous close
SAR 25.00
Year range
SAR 24.00 - SAR 40.00
Market cap
62.50M SAR
Avg Volume
315.00
P/E ratio
13.33
Dividend yield
-
Primary exchange
TADAWUL
Market news
AOL.com
28 minutes ago
Stop Chasing the S&P 500. This Vanguard ETF Has Beaten It Over the Last Decade.
0.00%
Financials
Income Statement
Revenue
Net income
| (SAR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 5.31M | 3.01% |
Operating expense | 7.54M | 1,134.90% |
Net income | 311.76K | -81.36% |
Net profit margin | 5.87 | -81.92% |
Earnings per share | — | — |
EBITDA | 750.41K | -63.22% |
Effective tax rate | 40.40% | — |
Balance Sheet
Total assets
Total liabilities
| (SAR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | 2.48M | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (SAR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 311.76K | -81.36% |
Cash from operations | 1.40M | -24.24% |
Cash from investing | -2.01M | -2,795.73% |
Cash from financing | -76.25K | -101.63% |
Net change in cash | -3.63M | -156.22% |
Free cash flow | — | — |
About
Founded
2012
Website
Employees
81
